探索海洋毒素:对化学反应性质和药物发现潜力的比较分析
Norma Flores-Holguín1, Joan S Salas-Leiva1, Erick J Núñez-Vázquez2
1Centro de Investigación en Materiales Avanzados SC, Chihuahua, Mexico.
Frontiers in chemistry
|November 29, 2023
概括
这项研究比较了水友性和脂友性海洋毒素,揭示了药物开发至关重要的共同特性. 多米酸 (DA) 显示出独特的相互作用能力和稳定性,具有治疗潜力.
科学领域:
- 海洋生物学 海洋生物学
- 毒理学 毒理学 毒理学
- 药用化学 医学化学
背景情况:
- 来自微生物的海洋毒素对生态系统和人类健康构成风险.
- 了解毒素的结构和特性对于缓解和治疗探索至关重要.
- 水友和脂友性质显著影响药物设计,分发和消除.
研究的目的:
- 为了比较分析水友和脂友海洋毒素.
- 检查毒素的反应性和生物可用性.
- 为了确定共享的分子特性,用于新药前体的开发.
主要方法:
- 两种水友和两种脂友海洋毒素的比较分析.
- 对反应性质的评估.
- 对生物可用性评分的评估.
主要成果:
- 在结构上不同的海洋毒素中发现了相似之处.
- 突出了多米酸 (DA) 的特殊相互作用能力和稳定性.
- 提供了对共享的分子性质的见解,指导药物发现.
结论:
- 海洋毒素之间的共同特性可以为未来的药物发现工作提供信息.
- 了解毒素的生物活性可以解开新的治疗可能性.
- 多米酸 (DA) 对潜在的生物医学应用具有独特的属性.
相关概念视频
Structure-Activity Relationships and Drug Design
729
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
729
Toxic Reactions: Overview
982
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
982
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Drug-Receptor Bonds
2.9K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.9K
Effects of Chemicals: Overview
1.3K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.3K
Antidotes
651
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
651


